Inclusion Criteria:

• Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements,
• Patient has, or is intended to receive or be treated with, an eligible Medtronic product.
• Patient is consented within the enrollment window of the therapy received, as applicable Additional criteria may be required, refer to Condition/Therapy Appendix for further guidance.

Exclusion Criteria:

• Patient who is, or is expected to be, inaccessible for follow-up.
• Patient is excluded by local law.
• Patient is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the PSR results (i.e., no required intervention that could affect interpretation of allaround product safety and/or effectiveness).

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 3/31/23. Questions regarding updates should be directed to the study team contact.